Spermidine
|
Basic information |
| Metabolite name | Spermidine |
 | HMDB0001257 |
 |
C00315 |
 |
1102 |
| Synonyms | Spermidine |
| No. of studies | 16 |
|
Basic information |
| Metabolite name | Spermidine |
| HMDB0001257 |
|
C00315 |
|
1102 |
| Synonyms | Spermidine |
| No. of studies | 16 |
|
Relationship between Spermidine and depression (count: 16) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M074 | Type1 | sCSDS group vs. control group | Faece | C57BL/6JJmsSlc mouse | Up |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1032 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1032 | Type2 | CUMS + Bupleurum chinense DC and Paeonia lactiflora Pall group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M1032 | Type2 | CUMS + Bupleurum chinense DC group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M1032 | Type2 | CUMS + Paeonia lactiflora Pall group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M1092 | Type1 | CMS group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M1093 | Type1 | CSDS group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M155 | Type1 | depressed suicide group vs. control group | Frontal cortex | Human | Up |
| Study M472 | Type3 | (2S,6S)-HNK group vs. control group | PC12 cell | Rat | Down |
| Study M604 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M604 | Type2 | CUMS + PBR group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M608 | Type2 | CUMS + Poria cocos group vs. CUMS group | Faece | Sprague-Dawley rat | Down |
| Study M691 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M691 | Type2 | CUMS + low dose of Chaihu-Baishao group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M691 | Type2 | CUMS + low dose of Baishao group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M830 | Type1 | corticosterone group vs. control group | Brain | Swiss mouse | Up |
| Study M830 | Type2 | corticosterone + acupoint catgut embedding group vs. corticosterone group | Brain | Swiss mouse | Down |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
| Study M869 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M869 | Type2 | CUMS + middle dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
| Study M883 | Type1 | MDD group vs. control group | Blood | Human | Up |
| Study M924 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M980 | Type1 | CMS group vs. control group | Olfactory bulb | C57BL/6J mouse | Down |